7 resultados
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national stage application of International Patent Application No. PCT/EP2014/068494, filed Sep. 1, 2014, which is a continuation-in-part of U.S. Ser. No. 14/014,650, filed Aug. 30, 2013, which is a continuation-in-part of
FIELD OF THE INVENTION
The present invention relates to compositions and methods for the treatment of neurological diseases and disorders. More particularly, this invention relates to novel combinatorial therapies for such diseases, including Alzheimer's and related diseases, Multiple Sclerosis,
FIELD OF THE INVENTION
The present invention relates to compositions and methods for the treatment of neurological diseases and disorders. More particularly, this invention relates to novel combinatorial therapies for such diseases, including Alzheimer's and related diseases, Multiple Sclerosis,
FIELD OF THE INVENTION
The present invention relates to combinations and methods for the treatment of neurological diseases and disorders. More specifically, the present invention relates to novel combinatorial therapy of neurological disorders, based on Baclofen and Acamprosate
FIELD OF THE INVENTION
The present invention relates to combinations and methods for the treatment of neurological diseases and disorders. More specifically, the present invention relates to novel combinatorial therapy of neurological disorders, based on Baclofen and Acamprosate
FIELD OF THE INVENTION
The present invention relates to combinations and methods for the treatment of neurological diseases and disorders. More specifically, the present invention relates to novel combinatorial therapy of neurological disorders, based on baclofen and acamprosate
FIELD OF THE INVENTION
The present invention relates to combinations and methods for the treatment of neurological diseases and disorders. More specifically, the present invention relates to novel combinatorial therapy of neurological disorders, based on baclofen and acamprosate